| Unique ID issued by UMIN | UMIN000054934 |
|---|---|
| Receipt number | R000062719 |
| Scientific Title | Development of a real-world database for cancer patients in Japan |
| Date of disclosure of the study information | 2024/07/11 |
| Last modified on | 2025/10/07 17:16:35 |
Development of a real-world database for cancer patients in Japan
Development of a real-world database for cancer patients in Japan
Development of a real-world database for cancer patients in Japan
Development of a real-world database for cancer patients in Japan
| Japan |
- Breast cancer
- Thoracic malignancy (non-small cell lung cancer, small cell lung cancer, etc.)
- Gastrointestinal cancer (pancreatic cancer, liver cancer)
| Gastroenterology | Hepato-biliary-pancreatic medicine | Pneumology |
| Endocrinology and Metabolism | Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
| Chest surgery | Breast surgery |
Malignancy
YES
To curate high-quality oncology real-world data based on existing and future medical records at the Nagoya University Hospital, and to conduct research utilizing this RWD for the furtherance of research and medical care for cancer in Japan
Efficacy
Real-world overall survival, time-to-next-treatment, progression-free survival, time-to-treatment-discontinuation etc.
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
Patients who meet all of the following criteria will be included in this study:
1. Patients who received care at Nagoya University Hospital between January 1, 2011 and December 31, 2028
2. Patients with a confirmed diagnosis of any of the following tumor types:
- Breast cancer
- Thoracic malignancy (non-small cell lung cancer, small cell lung cancer,etc)
- Gastrointestinal cancer (pancreatic cancer, liver cancer)
3. Patients aged 18 and above
4. Patient(or a legal surrogate) has either confirmed willingness to participate in the study through one of the following methods, or has not expressed a decline to participate.
- Written informed consent has been obtained using study-specific explanatory and consent documents.
- For eligible patients who visited the Nagoya University Hospital on or after January 1, 2011, and are already deceased, no objection to participation has been received from the patient's legal surrogate after being provided with an opportunity to decline participation in this study,provided that this does not contradict the explicit wishes expressed by the patient during their lifetime.
Surrogate: Spouse, parents, siblings, children/grandchildren, grandparents, relatives living together with the subject patient, or persons considered to be equivalent to such close relatives (excluding minors).
None
3000
| 1st name | Shoichi |
| Middle name | |
| Last name | Maruyama |
Nagoya University Hospital
Hospital Director
466-8560
65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan
052-741-2111
marus@med.nagoya-u.ac.jp
| 1st name | Toyone |
| Middle name | |
| Last name | Kikumori |
Nagoya University Hospital
Breast and Endocrine Surgery Department
466-8560
65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan
052-741-2111
kikumori@med.nagoya-u.ac.jp
Nagoya University Hospital
Flatiron Health K.K.
Profit organization
Flatiron Health K.K.
Nagoya University Hospital
Institutional Review Board of the Ethics Committee of Nagoya University Hospital
65 Tsurumai-cho, Nagoya-shi, Aichi Prefecture, Japan 466-8560
052-741-2111
ethics@med.nagoya-u.ac.jp
NO
| 2024 | Year | 07 | Month | 11 | Day |
Unpublished
Open public recruiting
| 2023 | Year | 11 | Month | 29 | Day |
| 2023 | Year | 11 | Month | 29 | Day |
| 2023 | Year | 12 | Month | 25 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
NA
| 2024 | Year | 07 | Month | 11 | Day |
| 2025 | Year | 10 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062719